Target: 2019-nCoV S-RBD IgG antibody
Sample: Human serum, plasma or whole blood
Specification: 1 Test/Kit; 5 Tests/Kit; 20 Tests/Kit; 50 Tests/Kit; 500 Tests/Kit
Global registration: European Union, England, Malaysia.
Various package specifications: Meet the needs of different scene detection.
Clinical significance: Auxiliary evaluate potency of 2019-nCoV vaccine.
High sensitivity and specificity: More than 1000 clinical samples were test, Clinical sensitivity higher than 91%, Clinical specificity higher than 95.6%.
Convenient : Without instrument operation.
Fast: The result can be obtained in 15 minutes.